TrialNature medicine2026

The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial.

Johann Bauersachs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.